Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

1.2K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.2K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.1K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

793
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
793
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

2.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.9K
Stimulants01:29

Stimulants

1.2K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping the genetic architecture of human cortical expansion and its links to neuropsychiatric disorders.

bioRxiv : the preprint server for biology·2026
Same author

Racialized Heteroscedasticity in Neuroimaging Features, Behavior Measures, and Neuroimaging-Based Predictive Models.

Research square·2026
Same author

Regional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder.

Nature communications·2026
Same author

Using connectome-based predictive models to reveal the systems standardized tests and clinical symptoms are reflecting.

Nature communications·2026
Same author

Effect sizes in human functional neuroimaging.

Research square·2026
Same author

Cortical reinstatement of causally related events sparks narrative insights by updating neural representation patterns.

Nature communications·2026

Related Experiment Video

Updated: Mar 15, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.9K

Methylphenidate Modulates Functional Network Connectivity to Enhance Attention.

Monica D Rosenberg1, Sheng Zhang2, Wei-Ting Hsu3

  • 1Department of Psychology, monica.rosenberg@yale.edu.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|September 16, 2016
PubMed
Summary
This summary is machine-generated.

Methylphenidate (Ritalin) enhances sustained attention by altering brain connectivity. This medication increases activity in attention-related networks and decreases it in others, suggesting a causal role for these networks in attention.

Keywords:
fMRIfunctional connectivitymethylphenidateneuromarkerpredictive markersustained attention

More Related Videos

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

11.1K
Measurement of Neurophysiological Signals of Ignoring and Attending Processes in Attention Control
09:37

Measurement of Neurophysiological Signals of Ignoring and Attending Processes in Attention Control

Published on: July 5, 2015

9.6K

Related Experiment Videos

Last Updated: Mar 15, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.9K
Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

11.1K
Measurement of Neurophysiological Signals of Ignoring and Attending Processes in Attention Control
09:37

Measurement of Neurophysiological Signals of Ignoring and Attending Processes in Attention Control

Published on: July 5, 2015

9.6K

Area of Science:

  • Neuroscience
  • Cognitive Neuroscience
  • Psychopharmacology

Background:

  • Human whole-brain functional connectivity patterns from fMRI data offer insights into cognitive abilities like sustained attention.
  • Connectome-based predictive modeling (CPM) has been developed to predict behavior from these connectivity patterns.
  • Previous research defined high-attention and low-attention networks using CPM, showing their potential as biomarkers for attention-deficit/hyperactivity disorder (ADHD).

Purpose of the Study:

  • To investigate the causal role of attention-related functional brain networks in sustained attention.
  • To examine how methylphenidate, a common ADHD treatment, modulates these attention networks in healthy adults.

Main Methods:

  • Healthy adults were administered methylphenidate or a placebo.
  • Whole-brain functional connectivity was measured using fMRI.
  • CPM was used to define high-attention and low-attention networks, and their strength was compared between groups.
  • Behavioral performance on a sustained attention task and a stop-signal task was assessed.

Main Results:

  • Individuals receiving methylphenidate exhibited increased high-attention network strength and decreased low-attention network strength compared to controls.
  • There was significant overlap between the identified high-attention network and networks showing increased connectivity under methylphenidate.
  • Network strength predicted behavioral performance on a stop-signal task.

Conclusions:

  • Methylphenidate appears to exert its effects on attention by modulating the strength of specific whole-brain functional connectivity networks.
  • These findings support a causal role for these identified networks in sustained attention.
  • Modulating whole-brain connectivity patterns may represent a therapeutic strategy for improving attention.